{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T05:29:08Z","timestamp":1695706148645},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 76-year-old man, who experienced prostate cancer biochemical relapse after 12 years from radical prostatectomy, underwent abdominal CT scan for restaging purposes, negative for metastases, and then <jats:sup>11<\/jats:sup>C-choline PET\/CT. The only finding was an area of focal uptake of radiotracer between the intestinal loops and the abdominal wall; after resection, the lesion demonstrated to be a metastasis from hepatocellular carcinoma (HCC), for which the patient had undergone liver resection 2 years earlier. This case proves that abnormal foci of <jats:sup>11<\/jats:sup>C-choline uptake in the peritoneum in HCC patients have to be kept in mind as possible sites of HCC-metastases.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003203","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T21:21:42Z","timestamp":1601500902000},"page":"703-704","source":"Crossref","is-referenced-by-count":0,"title":["Incidental Finding on 11C-Choline-PET\/CT of Hepatocellular Carcinoma Recurrence in a Prostate Cancer Patient With Negative Abdominal CT Scan"],"prefix":"10.1097","volume":"45","author":[{"given":"Priscilla","family":"Guglielmo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Pisu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Sanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bi Llie Joy","family":"Pung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Boero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s00259-015-3079-5","article-title":"Diagnostic accuracy of 11C-choline PET\/CT in comparison with CT and\/or MRI in patients with hepatocellular carcinoma","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/MNM.0b013e328350fb9f","article-title":"A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET\/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection","volume":"33","year":"2012","journal-title":"Nucl Med Commun"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/MNM.0000000000000719","article-title":"Refining the management of patients with hepatocellular carcinoma integrating 11C-choline PET\/CT scan into the multidisciplinary team discussion","volume":"38","year":"2017","journal-title":"Nucl Med Commun"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/17434440.2019.1608817","article-title":"Recent advances in PET probes for hepatocellular carcinoma characterization","volume":"16","year":"2019","journal-title":"Expert Rev Med Devices"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1158\/0008-5472.CAN-18-3837","article-title":"Transcriptomics associates molecular features with 18F-fluorocholine PET\/CT imaging phenotype and its potential relationship to survival in hepatocellular carcinoma","volume":"79","year":"2019","journal-title":"Cancer Res"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2967\/jnumed.108.052639","article-title":"Detection of hepatocellular carcinoma using 11C-choline PET: comparison with 18F-FDG PET","volume":"49","year":"2008","journal-title":"J Nucl Med"},{"key":"bib7-20230925","first-page":"B299","article-title":"Fluoromethylcholine PET in recurrent multifocal hepatoma","volume":"51","year":"2007","journal-title":"Australas Radiol"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00259-006-0164-9","article-title":"PET\/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET\/CT","volume":"33","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1586\/17474124.2015.1028363","article-title":"The evolving epidemiology of hepatocellular carcinoma: a global perspective","volume":"9","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003203","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:08:52Z","timestamp":1695622132000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003203","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,22]]}}}